Background COVID-19 has spread globally. Epidemiological susceptibility to COVID-19 has
been reported in patients with cancer. We aimed to systematically characterise clinical
features and determine risk factors of COVID-19 disease severity for patients with cancer
and COVID-19. Methods In this multicentre, retrospective, cohort study, we included all adult
patients (aged≥ 18 years) with any type of malignant solid tumours and haematological
malignancy who were admitted to nine hospitals in Wuhan, China, with laboratory-confirmed …

Background Several small studies on patients with COVID-19 and haematological
malignancies are available showing a high mortality in this population. The Italian
Hematology Alliance on COVID-19 aimed to collect data from adult patients with
haematological malignancies who required hospitalisation for COVID-19. Methods This
multicentre, retrospective, cohort study included adult patients (aged≥ 18 years) with
diagnosis of a WHO-defined haematological malignancy admitted to 66 Italian hospitals …